MAGRI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 5.201
EU - Europa 3.437
AS - Asia 2.828
SA - Sud America 527
AF - Africa 72
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.086
Nazione #
US - Stati Uniti d'America 5.073
PL - Polonia 1.313
CN - Cina 993
SG - Singapore 912
UA - Ucraina 500
IT - Italia 492
BR - Brasile 440
DE - Germania 284
VN - Vietnam 271
HK - Hong Kong 254
FI - Finlandia 217
FR - Francia 170
GB - Regno Unito 152
IN - India 104
TR - Turchia 90
RU - Federazione Russa 87
CA - Canada 78
IE - Irlanda 77
BD - Bangladesh 40
ID - Indonesia 34
AR - Argentina 29
MX - Messico 25
ZA - Sudafrica 23
BE - Belgio 22
NL - Olanda 21
SA - Arabia Saudita 21
SE - Svezia 20
CZ - Repubblica Ceca 19
EC - Ecuador 18
JP - Giappone 17
NG - Nigeria 17
AT - Austria 15
AU - Australia 15
IQ - Iraq 15
ES - Italia 14
PK - Pakistan 12
CO - Colombia 11
KE - Kenya 11
VE - Venezuela 9
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
KR - Corea 6
PY - Paraguay 6
UZ - Uzbekistan 6
CH - Svizzera 5
EG - Egitto 5
JM - Giamaica 5
JO - Giordania 5
KG - Kirghizistan 5
PH - Filippine 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BG - Bulgaria 4
BH - Bahrain 4
IL - Israele 4
NP - Nepal 4
PT - Portogallo 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
PA - Panama 3
PE - Perù 3
SI - Slovenia 3
UY - Uruguay 3
GR - Grecia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
AM - Armenia 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
PS - Palestinian Territory 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.086
Città #
Warsaw 1.308
Singapore 502
Ashburn 486
Fairfield 463
Woodbridge 342
Jacksonville 335
Ann Arbor 258
Hong Kong 252
San Jose 244
Chandler 226
Houston 225
Beijing 200
Brescia 194
Cambridge 182
New York 181
Seattle 173
Wilmington 162
The Dalles 154
Princeton 148
Helsinki 126
Los Angeles 114
Nanjing 109
Dearborn 91
Dublin 77
Lauterbourg 71
Istanbul 70
Dong Ket 68
Ho Chi Minh City 68
Munich 66
Des Moines 63
Council Bluffs 51
Dallas 51
Nanchang 48
São Paulo 47
Jinan 45
Shanghai 43
Shenyang 41
Turku 41
San Francisco 40
Buffalo 39
Hanoi 36
Hebei 36
Moscow 33
Orem 32
Milan 30
Chicago 28
Santa Clara 28
Toronto 28
Jakarta 26
Redondo Beach 26
Changsha 25
Jiaxing 23
Boardman 22
Brussels 22
Chennai 22
Rio de Janeiro 21
San Diego 21
Tianjin 19
Montreal 18
Phoenix 18
Rome 18
Hangzhou 17
Washington 17
Zhengzhou 17
Abuja 16
Brooklyn 16
London 16
Frankfurt am Main 15
Haikou 15
Tokyo 14
Lancaster 13
Nuremberg 13
Atlanta 12
Bolzano 12
Denver 12
Johannesburg 12
Lanzhou 12
Ningbo 12
Brno 11
Da Nang 11
Guangzhou 11
Mumbai 11
Verona 11
Belo Horizonte 10
Mexico City 10
Stockholm 10
Fuzhou 9
Haiphong 9
Jeddah 9
Naples 9
Manchester 8
Paris 8
Redwood City 8
Salvador 8
San Mateo 8
Brasília 7
Düsseldorf 7
Guayaquil 7
Kunming 7
Nairobi 7
Totale 8.373
Nome #
"GenotypeColour": colour visualisation of SNPs and CNVs 335
SNP array and FISH analysis of a proband with a 22q13.2- 22qter duplication shed light on the molecular origin of the rearrangement 335
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 320
New Copy Number Variations in Schizophrenia 317
ITGB2 mutation combined with deleted ring 21 chromosome in a child with leukocyte adhesion deficiency 305
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 301
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 263
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 251
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 229
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 225
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 225
New biological pathways for major depression: gene expression decomposition in G x E components 211
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 208
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 207
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 206
Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder. 199
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 187
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 186
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 185
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder 180
Analysis of Copy Number Variations in Schizophrenia Italian Patients 171
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 170
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 168
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 167
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 165
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 164
De novo deletion of chromosome 2q24.2 region in a mentally retarded boy with muscular hypotonia 158
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 145
RESEARCH OF THE DISEASE-GENE IN A FAMILY AFFECTED BY A TYPE OF CEREBELLAR ATAXIA WITH AN UNKNOWN MOLECULAR DEFECT 144
Saami and Berbers--an unexpected mitochondrial DNA link 144
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 139
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 139
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 136
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 134
Origin, diffusion and differentiation of Y-chromosome haplogroups E and J: inferences on the Neolithization of Europe and later migratory events in the Mediterranean area 133
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 133
The molecular dissection of mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the European gene pool 132
Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in Europe 131
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 130
SNP array and FISH analysis of a proband with a 22q13.2- 22qter duplication shades light on the molecular origin of the rearrangement. 128
Detection of high level of autozygosity in a group of Italian schizophrenia patients 128
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 128
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 124
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 124
New Copy Number Variations in Schizophrenia Italian Patients 123
Application of SNP-arrays, FISH and genotypecolour in molecular diagnosis of mental retardation 123
Identification and characterization of an Xq26-27 duplication in a male with psycomotor retardation and craniofacial dysmorphisms 121
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 121
Long-term effects of HLA A*03:01 genotype on anti-SARS-CoV-2 Spike antibody levels following BNT162b2 vaccine 120
Rna editing and modifications in mood disorders 118
Analysis of Citalopram response heterogeneity among STAR*D patients using in-silico methods 117
Genome wide study of Italian schizophrenia patients 116
Ricerca del gene malattia in una famiglia affetta da una forma di atassia cerebellare a difetto molecolare sconosciuto 115
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 114
Mitochondrial DNA haplogroups and age at onset of schizophrenia 113
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 111
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 109
Identificazione mediante exome sequencing di una variante del gene RBMXL1 in una famiglia affetta da atassia cerebellare pura 109
Combined DOCK8 and CLEC7A mutations causing immunodeficiency in three brothers with diarrhea, eczema and infections. 108
Genome-wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA-A*03:01 allele 107
Application of SNP-Arrays, FISH and GenotypeColour in Molecular Diagnosis of Mental Retardation 106
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 106
Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression 103
Y-chromosome and mtDNA polymorphisms in Iraq, a crossroad of the early human dispersal and of post-Neolithic migration 103
Mitochondrial DNA haplogroups do not play a role in the variable phenotypic presentation of the A3243G Mutation 102
Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium 101
GenotypeColour: a coloured way of visualising SNPs and CNVs 97
Assessment of haptoglobin alleles in autism spectrum disorders 95
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 94
GenotypeColour: un modo colorato di rappresentare SNP e CNV 92
From surnames to history of Y chromosomes: the Sardinian population as a case test 92
The 49af Haplotype 11 is a new marker of the Eu19 lineage which traces migrations from Northern regions of the Black Sea 91
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 90
Whole blood transcriptome characterization of 3xTg‐AD mouse and its modulation by transcranial direct current stimulation (TDCs) 88
Genome-wide analysis of RNA editing levels in human blood identified interactions with mRNA processing genes and suggested correlations with biological and drug-related variables 84
Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress 84
Genome-wide analysis of RNA-editing levels in human blood identifies interactions with mRNA processing genes and suggests correlation with biological and drug-related variables 83
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 80
The role of MED22 and its transcriptional interactions with childhood trauma and trauma-focused psychotherapy in patients with major depressive disorder 77
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 73
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 72
Identificazione dei geni di suscettibilità per schizofrenia e disturbo bipolare in un selezionato campione di pazienti italiani 70
Profiling of miR-98-5p, miR-130a-3p, and miR-1246 levels in tissue and liquid biopsies of patients with hepatocellular carcinoma. 60
Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics 59
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 35
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 34
MiR-98-5p, miR-130a-3p, and miR-1246 levels in tissue and liquid biopsies of patients with hepatocellular carcinoma 17
Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility/resilience in the hippocampus 15
L'impiego dello Storytelling Thinking® nel trattamento dei pazienti affetti da Disturbo da Gioco d'Azzardo 10
Totale 12.368
Categoria #
all - tutte 50.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 0 0 0 0 0 142 104
2021/2022686 56 127 31 10 10 25 36 27 42 90 67 165
2022/2023608 89 8 23 61 60 163 3 68 86 11 17 19
2023/2024744 42 21 66 65 40 187 18 17 144 29 9 106
2024/20251.552 13 25 12 210 148 128 108 58 168 126 308 248
2025/20263.285 303 408 221 466 382 257 548 108 210 305 77 0
Totale 12.368